U.S. Vascular Grafts Market Size, Share & Trends Analysis Report By Product (Hemodialysis Access Grafts, Endovascular Stent Grafts), By Application (Cardiac Aneurysm, Kidney Failure, Vascular Occlusion), By Raw Material, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Application
                        1.2.3. Raw material
                        1.2.4. Country scope
                        1.2.5. Estimates and forecast timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                            1.7.1.1. Approach 1: Commodity flow approach
                        1.7.2. Volume price analysis (Model 2)
                            1.7.2.1. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. Application outlook
                        2.2.3. Raw material outlook
                        2.2.4. Country outlook
                    2.3. Competitive Insights
Chapter 3. Vascular Grafts Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing prevalence of cardiovascular diseases
                            3.2.1.2. Technological advancements in vascular surgery
                            3.2.1.3. Rising demand for vascular access for hemodialysis
                        3.2.2. Market restraint analysis
                            3.2.2.1. High cost of vascular graft procedures
                            3.2.2.2. Risk of complications and graft failure
                    3.3. Vascular Grafts Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. Vascular Grafts Market: Product Estimates & Trend Analysis
                    4.1. Vascular Grafts Market: Product Dashboard
                    4.2. Vascular Grafts Market: Product Movement Analysis
                    4.3. Vascular Grafts Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    4.4. Hemodialysis Access Grafts
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Endovascular Stent Grafts
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Coronary Artery By-Pass Grafts
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.7. Vascular Grafts for Aorta Disease
                        4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.8. Peripheral Vascular Grafts
                        4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Vascular Grafts Market: Application Estimates & Trend Analysis
                    5.1. Vascular Grafts Market: Application Dashboard
                    5.2. Vascular Grafts Market: Application Movement Analysis Vascular Grafts Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    5.3. Cardiac Aneurysm
                        5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.2. Endovascular Stent Graft
                            5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.3. Vascular Graft
                            5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.4. Kidney Failure
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Vascular Occlusion
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. Coronary Artery Disease
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Vascular Grafts Market: Raw Material Estimates & Trend Analysis
                    6.1. Vascular Grafts Market: Raw Material Dashboard
                    6.2. Vascular Grafts Market: Raw Material Movement Analysis
                    6.3. Vascular Grafts Market Size & Forecasts and Trend Analysis, by Raw Material, 2018 to 2030 (USD Million)
                    6.4. Synthetic Vascular Grafts
                        6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.2. Polytetrafluoroethylene (PTFE) Grafts
                            6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.3. Polyester Grafts
                            6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.4. Polyurethane Grafts
                            6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Biological Vascular Grafts
                        6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.2. Autografts
                            6.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.3. Allografts
                            6.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.4. Xenografts
                            6.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Hybrid Vascular Grafts
                        6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. Medtronic
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Modality benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. Terumo Corporation
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Modality benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. LeMaitre Vascular, Inc.
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Modality benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. B. Braun Melsungen AG
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Modality benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Getinge AB
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Modality benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. BD (Becton Dickinson)
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Modality benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. W. L. Gore and Associates, Inc.
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Modality benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. Abbott
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Modality benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. MicroPort Scientific Corporation
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Modality benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. Endologix
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Modality benchmarking
                            7.3.13.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 U.S. Vascular Grafts Devices Market, By Product, 2018 - 2030 (USD Million)
Table 3 U.S. Vascular Grafts Devices Market, By Application, 2018 - 2030 (USD Million)
Table 4 U.S. Vascular Grafts Devices Market, By Raw Material, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Vascular Grafts Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling For Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Vascular Grafts: Market Outlook
Fig. 10 Vascular Grafts Market Competitive Insights
Fig. 11 Parent Market Outlook
Fig. 12 Related/Ancillary Market Outlook
Fig. 13 Penetration And Growth Prospect Mapping
Fig. 14 Industry Value Chain Analysis
Fig. 15 Vascular Grafts Market Driver Impact
Fig. 16 Vascular Grafts Market Restraint Impact
Fig. 17 Vascular Grafts Market Strategic Initiatives Analysis
Fig. 18 Vascular Grafts Market: Product Movement Analysis
Fig. 19 Vascular Grafts Market: Product Outlook And Key Takeaways
Fig. 20 Hemodialysis Access Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 21 Endovascular Stent Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 22 Coronary Artery By-Pass Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 23 Vascular Grafts For Aorta Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 24 Peripheral Vascular Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 25 Vascular Grafts Market: Application Movement Analysis
Fig. 26 Vascular Grafts Market: Application Outlook And Key Takeaways
Fig. 27 Cardiac Aneurysm Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 28 Endovascular Stent Graft Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 29 Vascular Graft Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 30 Kidney Failure Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 31 Vascular Occlusion Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 32 Coronary Artery Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 33 Vascular Grafts Market: Raw Material Movement Analysis
Fig. 34 Vascular Grafts Market: Raw Material Outlook And Key Takeaways
Fig. 35 Synthetic Vascular Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 36 Polytetrafluoroethylene (PTFE) Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 37 Polyester Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 38 Polyurethane Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 39 Biological Vascular Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 40 Autografts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 41 Allografts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 42 Xenografts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 43 Hybrid Vascular Grafts Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 44 U.S. Vascular Grafts Market: Country Movement Analysis
Fig. 45 U.S. Vascular Grafts Market: Country Outlook And Key Takeaways
Fig. 46 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 47 Key Country Dynamics
Fig. 48 Company Market Share Analysis, 2023
Fig. 49 Strategic framework